First-in-man Dose Escalation Study of BAY1179470 in Patients With Advanced, Refractory Solid Tumors
Clinical trial NCT01881217 · COMPLETED
Trial details
- NCT number
- NCT01881217
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-28
- Primary completion
- 2016-03-18
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.